Medicaid spends more on antipsychotics – 
including Eli Lilly’s (LLY) Zyprexa, 
Bristol-Myers Squibb's (BMY) Abilify, 
AstraZeneca’s (AZN) Seroquel and Johnson & 
Johnson’s (JNJ) Risperdal - than any other class of medicine.

In 2008, the most recent year for which data was 
available, spending was $3.6 billion, up from 
$1.6 billion in 1999, according to Mathematica 
Policy Research data cited by the paper. And the 
number of people younger than 20 years old who 
receive prescriptions for antipsychotics that are 
paid for by Medicaid tripled during that period.

http://www.pharmalive.com/feds-probe-antipsychotic-prescriptions-for-children-in-medicaid?cid=nl.phrm01


"People Who experience mood swings, fear, voices and visions"